Details of the Drug Reposition

General Information of This Drug (ID: DM1WB8H)

Drug Name
Anti-CD19-CAR PBL   DM1WB8H
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Primary mediastinal B-cell lymphoma DIS7PRLV 2A81 Phase 1/2 [1]
Mantle cell lymphoma DISFREOV 2A85.5 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00924326) CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma